Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study

BACKGROUND: The second-line chemotherapy using paclitaxel, carboplatin, and bevacizumab for treating platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer frequently cause chemotherapy-induced peripheral neuropathy (CIPN), which is significantly associated with deterioration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Soo Jin, Yim, Ga Won, Paik, Haerin, Lee, Nara, Lee, Seungmee, Lee, Maria, Kim, Hee Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362815/
https://www.ncbi.nlm.nih.gov/pubmed/34132071
http://dx.doi.org/10.3802/jgo.2021.32.e73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362815/
https://www.ncbi.nlm.nih.gov/pubmed/34132071
http://dx.doi.org/10.3802/jgo.2021.32.e73

Ejemplares similares